Nobivac® NXT 3-Rabies

Product Description

  • Minimum age: 12 weeks
  • Volume: 0.5 mL
  • Administration: Subcutaneous
  • Duration of immunity: 3 years
  • Presentation: 25 x 1 dose

Label indication is 1 dose as early as 12 weeks of age, 1 booster injection a year later, then revaccinate every 3 years.

Enter the NXT era of rabies protection

With Nobivac® NXT 3-Rabies, the first and only rabies vaccines for cats and dogs built on RNA particle technology.

No more than what’s necessary in every vial

0.5-mL dose. Adjuvant-free.
Preservative-free.

Multilayered immune system activation

RNA particle technology creates powerful antibody and cell-mediated immune responses.

Performance without compromise

Robust and reliable efficacy, with demonstrated safety.

Always read the labels to determine whether the products are suitable for the animals to be vaccinated. As with all vaccines, the efficacy of a product may vary depending on the animal’s current health state and its environment.

Uncover the science behind Nobivac® NXT

  • Delivers the RNA sequence of a pathogen’s specific gene of interest (GOI) in a targeted way to the dendritic cell
  • The GOI is unpackaged and, for a limited time, makes multiple copies of itself
  • The copies of the GOI are translated into large amounts of antigen, which stimulates a broad and balanced immune response

A first in companion animal vaccines, a leap in protection

Order Nobivac® NXT 3-Rabies today from  your preferred distribution center

Partnering for progress to combat rabies together

Every Nobivac® vaccine administered helps provide ongoing support and vaccine donations through the Afya Program.

NOBIVAC® is a registered trademark of Intervet International B.V., used under license.